Moderna Doesn't Plan to Enforce Coronavirus Vaccine Patents During Pandemic
Drugmakers live and die by the exclusivity provided by patents on their medications. Generic competition or even a branded competitor can substantially cut a company's market share.
But Moderna (NASDAQ: MRNA) is putting society ahead of its bottom line. The biotech announced on Thursday that it won't enforce patents for its coronavirus vaccine during the COVID-19 pandemic.
The company noted: "We feel a special obligation under the current circumstances to use our resources to bring this pandemic to an end as quickly as possible. Accordingly, while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic."
Source Fool.com
